Longitudinal Associations Between Cardiometabolic Risk Markers and Cognitive Function in Middle-Aged and Older

Sooyeun Choi1, Taeyoung Park2, Youjin Je1

  • 1Department of Food and Nutrition, Kyung Hee University, Seoul, South Korea.

Insights

Increases in insulin resistance and blood pressure are linked to cognitive decline in adults over 50. These cardiometabolic risk factors particularly affect middle-aged individuals and may impact specific cognitive functions like memory.

Area of Science:

  • Gerontology
  • Neuroscience
  • Cardiology

Background:

  • Dementia and cardiometabolic diseases share long prodromal phases, making temporal relationship assessment challenging.
  • Existing research on cardiometabolic risk markers and cognitive function yields inconsistent findings.
  • Understanding these associations is crucial for early intervention strategies.

Purpose of the Study:

  • To investigate the longitudinal associations between cardiometabolic risk markers and cognitive function in middle-aged and older adults.
  • To identify specific risk markers that predict cognitive decline.
  • To explore age- and domain-specific effects on cognition.

Main Methods:

  • Longitudinal analysis of a population-based cohort of 1255 cognitively normal Koreans aged ≥50 years.
  • Repeated assessments of cardiometabolic risk markers and Korean Mini-Mental State Examination (K-MMSE) scores.
  • Multivariable linear regression and generalized estimating equation models were employed.

Main Results:

  • Increased homeostasis model assessment of insulin resistance (HOMA-IR) and fasting insulin levels were associated with cognitive decline (lower K-MMSE scores).
  • These associations were more pronounced in adults aged ≤65 years, with increased HOMA-IR and blood pressure linked to K-MMSE score declines.
  • Blood pressure increases correlated with memory decline, while HOMA-IR increases showed a marginal association with visuospatial ability decline.

Conclusions:

  • Longitudinal increases in insulin resistance and blood pressure are significant predictors of cognitive decline.
  • Middle-aged adults (≤65 years) appear particularly vulnerable to these cardiometabolic influences on cognition.
  • Cardiometabolic risk factors may differentially impact specific cognitive domains, highlighting the need for targeted interventions.
Abstract

Related Concept Videos

Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...